Department for Work and Pensions

home

Site navigation


Care and mobility considerations

Stage 1 and 2 disease

Long term side effects of treatment are infertility and early menopause. There are unlikely to be any long term care and mobility needs after treatment. The exception to this is the enduring but rare side effects of chemotherapy. Needs are likely to arise when disease recurs.

Stage 3 disease

Long term side effects of treatment are infertility and early menopause. There are no long term disabling effects other than the rare enduring side effects of chemotherapy. Recurrent disease is common and may occur only a few months after treatment of initial disease – up to date medical evidence from the treating hospital will be important.

Stage 4 disease

Survival for two years after diagnosis with this stage of disease is a good outcome. Most of these people are terminally ill. Those that are fit enough to have surgery are likely to go on to have chemotherapy. A proportion may have many of the problems of the recurrent disease group described above.

Problems specific to ovarian cancer include:

Metastatic and recurrent disease

The aim of treatment is to remove the cancer and try to get that person into remission usually with chemotherapy. Remission may last for a variable length of time. During remission a woman would be expected to be well with no disabling effects. Once disease has returned and remission has ended it is a case of controlling the disease for as long as possible. Further chemotherapy and/or surgery or radiotherapy may induce a second shorter remission but it will not cure it. For some women 4 – 6 lines of treatment may be given in this way over a number of years.

There may be disabling effects from metastatic disease anywhere in the body including:

Click on the link for details of:

Amended April 2008